Every hydrogen water trial published before 2025 asked some version of the same question — does it move a marker of oxidative stress, inflammation, or exercise recovery? A study out of Serbia and Hungary this year asked something nobody in this field had tested directly: does hydrogen-rich water change how much a person wants to eat.
The trial is small. The authors call their own findings exploratory. But the questions it raises — appetite, cravings, a hormone called GLP-1 that most people now recognize from the Ozempic conversation — are new territory for hydrogen research, worth reporting carefully.
The New Trial: HYDRAPPET and Hydrogen-Rich Water's Appetite Signal
Researchers led by Nikola Todorovic at the University of Novi Sad, working with colleagues in Hungary and Canada, published the HYDRAPPET trial in Medicina in July 2025. Thirty-six adults with obesity — 24 women, 12 men, average age 42 — were randomized to drink either 1.0 liter of hydrogen-rich water (15 mg of dissolved H₂) or 1.0 liter of identical-looking control water daily for eight weeks. Neither participants nor researchers knew who was in which group until the trial ended.
At the close of eight weeks, the hydrogen-water group showed significantly reduced food cravings, improved subjective sleep quality, lower total and LDL cholesterol, and higher circulating GLP-1 — the same appetite-regulating hormone targeted by newer prescription weight-management drugs — compared to the control group. No severe adverse events were reported in either arm.
What the Researchers Actually Measured
A single p-value doesn't tell the whole story, so it's worth walking through what each outcome measure actually captured.
Cravings and Appetite Regulation
Participants completed standardized craving and appetite questionnaires before and after the intervention. The hydrogen-water group reported a significant reduction in food cravings relative to control (p = 0.05) — a self-reported measure, not a lab value, and one the study authors were careful to describe as a novel finding requiring replication rather than a settled result.
Sleep Quality and GLP-1
Subjective sleep quality improved in the hydrogen-water group (p = 0.05), alongside a measurable increase in plasma GLP-1 (p = 0.05). GLP-1 is a gut-derived hormone that signals fullness to the brain and slows gastric emptying; it's the same biological pathway that drugs like semaglutide work by mimicking. The HYDRAPPET authors were explicit that their study measured an association, not a mechanism proven in this trial — GLP-1 rose, cravings fell, and the two numbers moved together, but the study wasn't designed to prove one caused the other.
Cholesterol
Total cholesterol dropped by a statistically significant margin (p = 0.02), and LDL cholesterol fell as well (p = 0.04) — a finding that lines up with the broader lipid research covered in our hydrogen water and cholesterol review.
Why Appetite Is a New Question for Hydrogen Research
Most of the organ-system research this publication has covered — bone, joints, blood sugar, cholesterol — traces back to a study design researchers have run for close to two decades: give people hydrogen water, measure a biomarker, compare to placebo. Appetite regulation asks something different. It treats hydrogen water as a potential input into the gut-brain signaling system, not just an antioxidant delivery method. That's a meaningfully different research question, and the fact that it produced a positive early signal is one reason this trial is getting attention beyond the usual hydrogen-research circles.
The Broader Metabolic Research Behind This Trial
HYDRAPPET didn't appear out of a vacuum. It sits on top of roughly fifteen years of published research connecting hydrogen-rich water to metabolic markers — glucose, lipids, body composition — that overlap meaningfully with appetite and weight.
Cholesterol and Glucose Metabolism, 2008
One of the earliest human hydrogen water trials, led by Kajiyama and colleagues, gave 36 patients with type 2 diabetes or impaired glucose tolerance 900 mL of hydrogen-rich water daily for eight weeks in a randomized, double-blind crossover design. Researchers reported reduced LDL cholesterol and improved glucose tolerance — the same glucose-metabolism thread our hydrogen water and blood sugar article covers in more depth.
Body Composition Over 24 Weeks
LeBaron and colleagues ran a longer trial: 60 adults with metabolic syndrome, randomized to high-concentration hydrogen water or placebo for 24 weeks. The hydrogen group showed significant reductions in blood cholesterol and glucose, improved hemoglobin A1c, and better inflammation markers compared to placebo — and the researchers noted a mild reduction in body mass index and waist-to-hip ratio in the hydrogen group as well, though they were careful to frame it as a trend worth confirming rather than a headline finding.
Waist Circumference and Electrolyzed Hydrogen Water
A more recent three-month randomized trial in 181 adults with metabolic syndrome tested electrolyzed hydrogen water against filtered water and reported a significantly greater reduction in waist circumference in the hydrogen-water group — but only among participants who also maintained high physical activity, a detail the authors flagged rather than buried. It's part of the same metabolic picture our hydrogen water and metabolic health article explores through the liver research.
The Mechanism Researchers Are Exploring
None of these trials happened by accident. There's a mechanistic thread researchers have been pulling on since the field's earliest days.
Selective Antioxidant Action
Ohsawa and colleagues, publishing the field's foundational paper in Nature Medicine in 2007, proposed that molecular hydrogen acts as a selective antioxidant — preferentially neutralizing the most damaging reactive oxygen species while leaving the ROS involved in normal cell signaling largely alone. Metabolic dysfunction, including the low-grade inflammation associated with obesity, is closely tied to oxidative stress. That's the thread connecting a 2007 stroke-model paper to a 2025 appetite study.
FGF21 and Energy Metabolism
A mouse study by Kamimura and colleagues found that long-term hydrogen-water drinking in obese, diabetic mice was associated with increased hepatic expression of FGF21 — a hormone that promotes fatty-acid and glucose expenditure — alongside reduced plasma glucose, insulin, and triglycerides, and better-controlled body weight despite no change in food or water intake. Worth being precise here: this is mouse data, not human data, and no published human trial has confirmed the same FGF21 pathway. It's a plausible mechanism researchers point to, not a proven one.
Where This Leaves the Evidence
Nobody researching molecular hydrogen claims it replaces diet, exercise, or medical care for weight management. The honest framing this evidence supports right now is a real, published, peer-reviewed signal in one small placebo-controlled human trial — not proof, but not nothing either. Every study cited here is something a reader can look up directly.
Frequently Asked Questions
Does hydrogen water actually reduce appetite?
One 2025 randomized, double-blind, placebo-controlled trial reported significantly reduced food cravings in participants drinking hydrogen-rich water for eight weeks, alongside increased GLP-1. That's a genuine published signal in a well-controlled study — not a claim that hydrogen water treats obesity or replaces a weight-management plan. The study's own authors called it a novel finding requiring replication.
How much hydrogen water did the HYDRAPPET participants drink?
One liter daily — about 15 mg of dissolved hydrogen — for eight consecutive weeks.
Is hydrogen water a weight-loss product?
No published trial has tested hydrogen water as a standalone weight-loss intervention, and no one running this research is framing it that way. The published signal is around appetite regulation, cravings, and metabolic markers like cholesterol and GLP-1 — components of a broader picture, not a substitute for diet, exercise, or medical guidance.
Further Reading
For the broader PubMed literature on hydrogen water and metabolic health, see PubMed's indexed results for hydrogen-rich water and metabolic syndrome.
- Todorovic N, et al. (2025), Medicina. PMID: 40731927. The randomized, double-blind, placebo-controlled HYDRAPPET trial covered above — 36 adults with obesity, 8 weeks of hydrogen-rich water, reduced cravings and increased GLP-1.
- Todorovic N, Fernández-Landa J, Santibañez A, et al. (2023), Pharmaceuticals. PMID: 37259294. A systematic review and meta-analysis of seven trials finding that hydrogen-rich water intake was associated with significant reductions in total cholesterol, LDL, and triglycerides across clinical populations.
- Meng F, et al. (2025), Current Pharmaceutical Design. PMID: 39810534. A 2025 review of hydrogen-rich water's biological activities, including its proposed role in glucose and lipid metabolism, mitochondrial protection, and the intestinal barrier.
- LeBaron TW, Singh RB, Fatima G, et al. (2020), Diabetes, Metabolic Syndrome and Obesity. PMID: 32273740. A 24-week randomized trial in 60 adults with metabolic syndrome reporting improved cholesterol, glucose, HbA1c, and inflammation markers with high-concentration hydrogen water.
- Kajiyama S, Hasegawa G, Asano M, et al. (2008), Nutrition Research. PMID: 19083400. One of the earliest hydrogen water trials, reporting improved LDL cholesterol and glucose tolerance in patients with type 2 diabetes or impaired glucose tolerance.
- Ohsawa I, Ishikawa M, Takahashi K, et al. (2007), Nature Medicine. PMID: 17486089. The foundational paper proposing molecular hydrogen as a selective antioxidant — the mechanistic starting point for essentially every study that followed, including the metabolic trials above.
References
- Todorovic N, et al. The Effects of 8-Week Hydrogen-Rich Water Consumption on Appetite, Body Composition, Sleep Quality, and Circulating Glucagon-like Peptide-1 in Obese Men and Women (HYDRAPPET): A Randomized Controlled Trial. Medicina. 2025;61(7):1299. PMID: 40731927. PMC: PMC12300559.
- Kajiyama S, Hasegawa G, Asano M, et al. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutrition Research. 2008;28(3):137-143. PMID: 19083400.
- LeBaron TW, Singh RB, Fatima G, et al. The Effects of 24-Week, High-Concentration Hydrogen-Rich Water on Body Composition, Blood Lipid Profiles and Inflammation Biomarkers in Men and Women with Metabolic Syndrome: A Randomized Controlled Trial. Diabetes, Metabolic Syndrome and Obesity. 2020;13:889-896. PMID: 32273740. PMC: PMC7102907. DOI: 10.2147/DMSO.S240122.
- Kamimura N, Nishimaki K, Ohsawa I, Ohta S. Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice. Obesity (Silver Spring). 2011;19(7):1396-1403. PMID: 21293445.
- Moribe R, et al. Health Effects of Electrolyzed Hydrogen Water for the Metabolic Syndrome and Pre-Metabolic Syndrome: A 3-Month Randomized Controlled Trial and Subsequent Analyses. Antioxidants. 2024;13(2):145. PMID: 38397743. PMC: PMC10886336. DOI: 10.3390/antiox13020145.
- Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. 2007;13(6):688-694. PMID: 17486089.
- Todorovic N, Fernández-Landa J, Santibañez A, Kura B, Stajer V, Korovljev D, Ostojic SM. The Effects of Hydrogen-Rich Water on Blood Lipid Profiles in Clinical Populations: A Systematic Review and Meta-Analysis. Pharmaceuticals. 2023;16(2):142. PMID: 37259294. PMC: PMC9967957. DOI: 10.3390/ph16020142.
Holy Hydrogen products, including the Lourdes Hydrofix Premium Edition, are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease. All information on this site is provided for educational and general wellness purposes only and should not be considered medical advice. Always consult a qualified healthcare provider before beginning any new wellness practice, especially if you have a medical condition, are pregnant or nursing, or take prescription medications.